These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 33736522)

  • 1. Impact of a Pharmacist Intervention in the Emergency Department on the Appropriateness of Direct Oral Anticoagulants Prescribed in Venous Thromboembolism Patients.
    Bakey KH; Nguyen CN
    J Pharm Pract; 2022 Aug; 35(4):599-605. PubMed ID: 33736522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementation and Preliminary Clinical Outcomes of a Pharmacist-managed Venous Thromboembolism Clinic for Patients Treated With Rivaroxaban Post Emergency Department Discharge.
    DiRenzo BM; Beam DM; Kline JA; Deodhar KS; Weber ZA; Davis CM; Walroth TA
    Acad Emerg Med; 2018 Jun; 25(6):634-640. PubMed ID: 28921763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a pharmacist-led outpatient direct oral anticoagulant service.
    Ashjian E; Kurtz B; Renner E; Yeshe R; Barnes GD
    Am J Health Syst Pharm; 2017 Apr; 74(7):483-489. PubMed ID: 28336758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low persistence to rivaroxaban or warfarin among patients with new venous thromboembolism at a safety net academic medical center.
    Patel SM; Wang T; Outler DL; Elliott J; Knauss M; Peasah SK; Akbashev M
    J Thromb Thrombolysis; 2020 Feb; 49(2):287-293. PubMed ID: 31598931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Discharge Anticoagulation Education by Emergency Department Pharmacists at a Tertiary Academic Medical Center.
    Zdyb EG; Courtney DM; Malik S; Schmidt MJ; Lyden AE
    J Emerg Med; 2017 Dec; 53(6):896-903. PubMed ID: 28941557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacoeconomic, Medication Access, and Patient-Satisfaction Analysis of a Pharmacist-Managed VTE Clinic Compared to Primary Care Physician Outpatient Therapy.
    Howell CW; Walroth TA; Beam DM; Geik CA; Howell MM; Macik MR; Schmelz AN; DiRenzo BM
    J Pharm Pract; 2022 Apr; 35(2):212-217. PubMed ID: 35484867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of acute venous thromboembolism among a cohort of patients discharged directly from the emergency department.
    Bungard TJ; Ritchie B; Bolt J; Semchuk WM
    BMJ Open; 2018 Oct; 8(10):e022064. PubMed ID: 30385439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initiation of direct oral anticoagulants versus warfarin for venous thromboembolism: impact on time to hospital discharge.
    Basto AN; Fewel NP; Vo K; Stock EM; Ta M
    J Thromb Thrombolysis; 2018 Jan; 45(1):51-55. PubMed ID: 29086244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticoagulation Treatment and Outcomes of Venous Thromboembolism by Weight and Body Mass Index: Insights From the Veterans Health Administration.
    Perino AC; Fan J; Schmitt S; Guo JD; Hlavacek P; Din N; Kothari M; Pundi K; Russ C; Emir B; Turakhia MP
    Circ Cardiovasc Qual Outcomes; 2021 Nov; 14(11):e008005. PubMed ID: 34724801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of Direct Oral Anticoagulants Versus Traditional Therapies for Acute Venous Thromboembolism After Direct Discharge From the Emergency Department or After Hospitalization: An Audit of 16 Canadian Hospitals.
    Bungard TJ; Ritchie B; Bolt J; Thomson P; Semchuk WM
    Clin Ther; 2020 May; 42(5):873-881. PubMed ID: 32284189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rivaroxaban program for acute venous thromboembolism upon ED discharge, with focus on utility of commercially available dose pack.
    Chu A; Limberg J
    Am J Emerg Med; 2017 Dec; 35(12):1910-1914. PubMed ID: 28869100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the risk of venous thromboembolism (VTE) in ambulatory patients with cancer: Rationale and implementation of a pharmacist-led VTE risk assessment program in an ambulatory cancer centre.
    Pelletier R
    J Oncol Pharm Pract; 2021 Jun; 27(4):911-918. PubMed ID: 33757321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving the safety of anticoagulation initiation in patients discharged from the emergency department.
    Harding AM; Mitri E; Yeoh M
    Emerg Med Australas; 2023 Feb; 35(1):162-164. PubMed ID: 36283707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness analysis of doctor-pharmacist collaborative prescribing for venous thromboembolism in high risk surgical patients.
    Hale A; Merlo G; Nissen L; Coombes I; Graves N
    BMC Health Serv Res; 2018 Oct; 18(1):749. PubMed ID: 30285744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacist Practice Patterns Regarding Direct Oral Anticoagulants for Treatment of Venous Thromboembolism.
    Kaylor DM; Johnson AJ; Berardi SL; VanArsdale VM; Niemann MH
    Hosp Pharm; 2023 Apr; 58(2):200-204. PubMed ID: 36890962
    [No Abstract]   [Full Text] [Related]  

  • 16. Anticoagulant therapies for acute venous thromboembolism: a comparison between those discharged directly from the emergency department versus hospital in two Canadian cities.
    Bungard TJ; Ritchie B; Bolt J; Semchuk WM
    BMJ Open; 2018 Oct; 8(10):e022063. PubMed ID: 30385438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics and treatment patterns of patients with venous thromboembolism (VTE) transitioning from hospital to post-discharge settings.
    Burton T; Hlavacek P; Guo JD; Rosenblatt L; Mardekian J; Ferri M; Russ C; Kline JA
    Hosp Pract (1995); 2020 Oct; 48(4):196-205. PubMed ID: 32720816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evaluation of a collaborative pharmacist prescribing model compared to the usual medical prescribing model in the emergency department.
    Ogilvie M; Nissen L; Kyle G; Hale A
    Res Social Adm Pharm; 2022 Oct; 18(10):3744-3750. PubMed ID: 35581126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Which patients with unprovoked venous thromboembolism should receive extended anticoagulation with direct oral anticoagulants? A systematic review, network meta-analysis, and decision analysis.
    Djulbegovic M; Lee AI; Chen K
    J Eval Clin Pract; 2020 Feb; 26(1):7-17. PubMed ID: 31190408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct oral anticoagulant-related medication incidents and pharmacists' interventions in hospital in-patients: evaluation using reason's accident causation theory.
    Haque H; Alrowily A; Jalal Z; Tailor B; Efue V; Sarwar A; Paudyal V
    Int J Clin Pharm; 2021 Dec; 43(6):1693-1704. PubMed ID: 34215959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.